IVERIC BIO INC's ticker is and the CUSIP is 46583P902. A total of 6 filers reported holding IVERIC BIO INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $15,531,432 | +588.6% | 394,800 | +325.9% | 0.05% | +525.0% |
Q1 2023 | $2,255,391 | -54.9% | 92,700 | -60.3% | 0.01% | -33.3% |
Q4 2022 | $5,003,517 | -37.6% | 233,700 | -47.7% | 0.01% | -25.0% |
Q3 2022 | $8,023,000 | +244.0% | 447,200 | +84.5% | 0.02% | +300.0% |
Q2 2022 | $2,332,000 | -39.4% | 242,400 | +6.0% | 0.00% | 0.0% |
Q1 2022 | $3,847,000 | -26.3% | 228,600 | -26.8% | 0.00% | 0.0% |
Q4 2021 | $5,223,000 | -60.3% | 312,400 | -61.4% | 0.00% | -71.4% |
Q3 2021 | $13,151,000 | +27880.9% | 809,800 | +10697.3% | 0.01% | – |
Q2 2021 | $47,000 | -97.1% | 7,500 | -97.2% | 0.00% | -100.0% |
Q1 2021 | $1,627,000 | -0.7% | 263,200 | +11.1% | 0.00% | -33.3% |
Q4 2020 | $1,638,000 | +9.1% | 237,000 | -11.0% | 0.00% | -40.0% |
Q3 2020 | $1,501,000 | +305.7% | 266,200 | +267.2% | 0.01% | +150.0% |
Q2 2020 | $370,000 | +19.0% | 72,500 | -19.7% | 0.00% | -33.3% |
Q1 2020 | $311,000 | -70.6% | 90,300 | -26.8% | 0.00% | -57.1% |
Q4 2019 | $1,059,000 | – | 123,400 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Worth Venture Partners, LLC | 115,500 | $68,930 | 0.03% |
GROUP ONE TRADING LLC | 92,700 | $2,255,391 | 0.01% |
SIMPLEX TRADING, LLC | 89,200 | $2,170 | 0.00% |
JANE STREET GROUP, LLC | 167,400 | $4,072,842 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
JPMORGAN CHASE & CO | 6,700 | $163,000 | 0.00% |